Daclizumab (Zenapax) and ATG (Fresenius) as a part of quadruple induction immunosupression protocol in liver transplantation
P. Trunecka, S. Vitko, M. Ryska, H. Hrncarkova, F. Belina, P. Kolnik, J. SpicakVolume:
34
Year:
2001
Language:
english
DOI:
10.1016/s0168-8278(01)81000-x
File:
PDF, 145 KB
english, 2001